Biotech News

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

MiMedx (MDXG)MiMedx2026-06-25 13:46 ESTEarnings

MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, February 25, 2026.

Open original release

Related news

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces Launch of G4Derm® Plus

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces Launch of CHORIOFIX™

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces Restructuring and Cost Reduction Initiative

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces First Quarter 2026 Operating & Financial Results

View all latest news

MiMedx

MiMedx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

MDXGMiMedx2026-06-26 09:32 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MDXGMiMedx2026-06-26 09:32 EST

MIMEDX Announces Launch of G4Derm® Plus

MDXGMiMedx2026-06-26 09:32 EST

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MDXGMiMedx2026-06-26 09:32 EST

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

MDXGMiMedx2026-06-26 09:32 EST

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States